Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Market Consolidation
Price Transparency
Pharmaceuticals
System Reform
State Action
SLIHCQ Database
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
News & Opinions
Key Issues
All
HEALTHCARE MARKETS
-Provider Network
--Telehealth or Telemedicine
--Scope of Practice
--Any Willing Provider
--Network Adequacy
--Tiered Network or Narrow Network
-Competition
--Antitrust Enforcement
--Healthcare Consolidation
--Most Favored Nation (MFN)
--Certificate of Need (CON)
--Certificate of Public Advantage (COPA)
--Anti-Steering or Anti-Tiering
--Price Manipulation
--Competitive Bidding
--Trade Secret
-Rate Regulation
-ACA Marketplace
HEALTHCARE COSTS
-Cost Containment
--Shared Savings or Right to Shop
--Reference Pricing
--Prior Authorization
--Utilization Review
-Price Gouging
-Cost-Sharing or Out-of-Pocket Costs
-High Deductible Health Plan (HDHP)
-Health Savings Account (HSA) or Health Reimbursement Account (HRA)
-Benefit Design
-Provider Payment
--Value-Based Payment
--Bundled Payment
--Global Payment or Global Budget
--Capitation
--Population-Based Payment
--Shared Risk or Risk-Based Payment
--Facility Fee
HEALTHCARE SYSTEM REFORM
-Single Payer or Multi-Payer
-Public Option
-Delivery Reform
-Quality or Value-Based Reform
-Managed Competition
-Accountable Care Organization (ACO)
-Medicaid Reform or Medicaid Waiver
-Affordable Care Act (ACA)
-Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
-All-Payer Claims Database (APCD)
-Gag Clause or Non-Disclosure Agreement
-Surprise Billing or Balance Billing
-Quality Measure
PHARMACEUTICALS
-Drug Pricing
-Drug Formulary
-Pharmacy Benefit Manager (PBM)
-Pharmacy Regulation
--Clawback Restriction
-Biosimilar or Generic Competition
--Generic Competition Block or Delay
-Therapeutic Substitution
-Medicaid Pharmaceuticals
-Medicare Part D
-340B Drug Pricing Program
-Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
New U.S. Vertical Merger Rules Fall Flat for Antitrust Advocates
Victoria Graham
January 16, 2020
A court struck down a ban on pharma ‘price gouging.’ One state wants to revive it — and others could follow
Lev Facher
January 16, 2020
Using states as living laboratories to solve surprise medical billing
Robin Gelburd
January 15, 2020
Warren and Klobuchar Say They Can Lower Drug Prices Without Congress’ HelpWarren and Klobuchar Say They Can Lower Drug Prices Without Congress’ Help
Emmarie Huetteman
January 15, 2020
U.S. Targets Drug Pricing, No-Poach Deals for Antitrust Action in 2020
Brent Kendall
January 15, 2020
Loopholes Limit New California Law To Guard Against Lofty Air Ambulance Bills
Michelle Andrews
January 14, 2020
U.S. Health Care System Reform Is Not Yet at the Tipping Point
Stephen M. Shortell
January 14, 2020
The ACA is doing fine without a mandate penalty
Drew Altman
January 14, 2020
To the Contrary, Trump Has Tried to Weaken Protections for Pre-existing Conditions
Margot Sanger-Katz
January 13, 2020
Appeals court skeptical of Trump rule on TV drug ads
Jessie Hellmann
January 13, 2020
How state groups are working to lower healthcare prices
Harris Meyer
January 11, 2020
Trump administration tells Supreme Court no need to rush an Obamacare ruling
Robert Barnes
January 10, 2020
Arkansas Drug-Pricing Law Will Get Supreme Court Review
Jacklyn Wille
January 10, 2020
How States Are Responding To The Insulin Price Crisis
Dave Royse
January 10, 2020
The most expensive health care option of all? Do nothing.
Alice Miranda Ollstein
January 9, 2020
New Legislation to Control Drug Prices: How Do House and Senate Bills Compare? An Update
Billy Wynne and Alyssa Llamas
January 9, 2020
Next
